169447-76-1

Basic information

• Product Name: (S)-1-N-Boc-2-butylpiperazine
• Synonyms: (S)-1-N-Boc-2-butylpiperazine;(S)-1-Boc-2-butyl-piperazine;(2S)-1-N-BOC-2-BUTYLPIPERAZINE;(S)-1-Boc-2-Butylpiperazine ,98%;(S)-tert-Butyl 2-butylpiperazine-1-carboxylate
• CAS NO: 169447-76-1
• Molecular Formula: C₁₃H₂₆N₂O₂
• Molecular Weight: 242.35774
• Product Categories: Piperaizine
• Mol File: 169447-76-1.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 320.53 °C at 760 mmHg
• Flash Point: 147.652 °C
• Appearance: /
• Density: 0.964 g/cm³
• Vapor Pressure: 0.000316mmHg at 25°C
• Refractive Index: 1.459
• Storage Temp.: 2-8°C(protect from light)
• PKA: 8.49±0.40(Predicted)
• CAS DataBase Reference: (S)-1-N-Boc-2-butylpiperazine(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-1-N-Boc-2-butylpiperazine(169447-76-1)
• EPA Substance Registry System: (S)-1-N-Boc-2-butylpiperazine(169447-76-1)

Safety Data

• Hazardous Substances Data: 169447-76-1(Hazardous Substances Data)

Usage

General Description

"(S)-1-N-Boc-2-butylpiperazine" is a chemical compound with the molecular formula C15H30N2O2. It is a derivative of piperazine, a heterocyclic amine with diverse pharmacological activities. The compound consists of a piperazine ring with a butyl group and a N-Boc protecting group attached to it. (S)-1-N-Boc-2-butylpiperazine has potential applications in medicinal chemistry and drug discovery due to its ability to interact with various biological targets. It is also used as a building block in the synthesis of diverse pharmaceuticals and bioactive molecules. Its stereochemistry and structural features contribute to its unique properties and potential biological activities.

InChI:InChI=1/C13H26N2O2/c1-5-6-7-11-10-14-8-9-15(11)12(16)17-13(2,3)4/h11,14H,5-10H2,1-4H3/t11-/m0/s1

Upstream product

• 169447-74-9 1-Benzyl-3(S)-n-butylpiperazine-2,5-dione 
• 175357-61-6 (S)-1-Benzyl-3-butyl-piperazine 
• 6404-28-0 Boc-Nle-OH 
• 24424-99-5 di-tert-butyl dicarbonate 
• 169447-75-0 4-Benzyl-1-tert-butoxycarbonyl-2(S)-n-butylpiperazine 

Downstream Products

• 205679-66-9 ((S)-3-Butyl-piperazin-1-yl)-(2,3-dimethyl-phenyl)-methanone 
• 169447-77-2 {(R)-1-[(S)-2-Butyl-4-(2,3-dimethyl-benzoyl)-piperazin-1-ylmethyl]-2-tritylsulfanyl-ethyl}-carbamic acid tert-butyl ester 
• 169448-30-0 {(R)-1-[(S)-2-Butyl-4-(naphthalene-1-carbonyl)-piperazin-1-ylmethyl]-2-tritylsulfanyl-ethyl}-carbamic acid tert-butyl ester 
• 169447-78-3 1-tert-butoxycarbonyl-2(S)-n-butyl-4-(2,3-dimethylbenzoyl)piperazine 

Relevant articles and documents

17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases

In its many embodiments, the present invention provides a novel class of compounds as inhibitors of type 3 17β-hydroxysteroid dehydrogenase, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of

Inhibitors of farnesyl-protein transferase

The present invention is directed to compounds which inhibit farnesyl-protein transferase (FTase) and the farnesylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting farnesyl-protein transferase and the farnesylation of the oncogene protein Ras. The compounds of formula A are representative of the compounds of the present invention: STR1